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ABSTRACT. In the newborn period, infants prenatally exposed to 
cocaine and other drugs show low scores on the Neonatal Behavioral 
Assessment Scale. Beyond that period, research is limited on the effects 
of prenatal drug exposure on neurobehavioral functioning. In this study 
we compared infants exposed to cocaine and other drugs and control 
infants from low socioeconomic backgrounds on measures of neurobe- 
havioral functioning during neuromotor assessment at 1, 4 and 7 
months of life. None of the measures of neurobehavioral functioning 
showed any significant group differences. This study did not support 
the hypothesis of disrupted neurobehavioral functioning beyond the 
neonatal period in infants exposed to drugs prenatally. [Article copies 
available for a fee froin The Haworth Document Delivery Service: 
1-800-342-9678. E-mail address: getiiifo@ha worthpressitic. coin] 
Yvette Blanchard, ScD, PT, is Assistant Professor of Physical Therapy, Physical 
Therapy Program, University of Hartford, CT. Patricia E. Suess, PhD, is Data Ana- 
lyst, Child and Family Research, LLEINICHD, NIH, Bethesda, MD. Marjorie 
Beeghly, PhD, is Assistant Professor of Pediatrics, Harvard Medical School and 
Research Director, Child Development Unit, Children’s Hospital, Boston, MA. 
Address correspondence to: Yvette Blanchard, University of Hartford, Physical 
Therapy Program, 200 Bloomfield Avenue, West Hartford, CT 0611 7. 
The first author would like to thank Linda Fetters, PliD, fl, and Wendy Coster, OT, 
PhD, from Boston University for their assistance and support during the dissertation 
phase of this project. 
This work was supported by grants to the first author from the Fonds pour la 
Formation de Chercheurs et I’Aide a la Recherche, Ste-Foy, Quebec, Canada and from 
the Physiotherapy Foundation of Canada, Toronto, Ontario, Canada, and in part by a 
grant from the National Institute of Drug Abuse, Neuromotor Functioning in Cocaine- 
Exposed Infants. E. Tronick, PhD, #5ROlDA06882. 
Physical & Occupational Therapy in Pediatrics, Vol. 18(3/4) 1998 





























































20 PHYSICAL & OCCUPATIONAL THERAPY IN PEDIATHCS 
Since the 1980s, the availability of crack cocaine at low cost has contrib- 
uted to an increase in the number of pregnant women who use i t  as well as 
other illegal drugs during pregnancy.' Reported incidences of prenatal co- 
caine use vary from 8% to 18%,2-5 with a study conducted in Detroit reveal- 
ing an incidence as high as 31% on meconium testing.6 Due to its low 
molecular weight and its water and lipid solubility, cocaine readily crosses 
the placenta and the fetal blood-brain barrier.7 Cocaine affects the mono- 
aminergic neurotransmitter system (dopamine, norepinephrine and serotonin) 
in  the central nervous system (CNS) through its action on the neurotransmit- 
ter release, reuptake, and recognition at the synaptic j ~ n c t i o n . ~ - ~  In humans, 
these neurotransmitters are present in neural pathways that prqject to brain 
areas involved in neurologic and behavioral functions including arousal, 
regulation of attention, response to sensory stimuli, and the modulation of 
mood states. lo, 
Neurotransmitters play an important role in fetal brain development 
through their influence on neuronal migration and differentiation, synaptic 
proliferation and on the development of receptor Although full 
scientific support for the suspected cocaine-induced changes in the human 
fetal neurotransmitter system and their ensuing neurodevelopmental conse- 
quences is still lacking, preliminary research has shown results suggestive of 
such a relationship. In a recent study with newborn infants, Mirochnick and 
colleagues14 showed that plasma norepinephrine concentrations were higher 
in infants who had been prenatally exposed to cocaine and mari.juana than in 
unexposed infants. Among the exposed infants, plasma norepinephrine con- 
centrations were associated with a decreased responsivity to social and non- 
social auditory and visual stimuli and higher levels of depressed behavior on 
the Neonatal Behavioral Assessment Scale (NBAS). Of note, these associa- 
tions remained significant even when controlling for the effects of prenatal 
marijuana exposure. In a rare study with human infants, Needlman and his 
colleagues15 examined the relation between prenatal cocaine exposure and 
the presence of monoamine precursors and metabolites in the central nervous 
system. Relative to unexposed infants, infants who had been prenatally ex- 
posed to cocaine had decreascd levels of homovanill ic acid, the principal 
metabolite of dopamine, in their cerebrospinal fluid. These findings suggest 
that prenatal cocaine exposure may result in changes in central dopaminergic 
systems in the human neonate.15 
Many investigators have reported that prenatal cocaine and polydrug ex- 
posure is significantly related to compromised infant neurobehavioral pcrfor- 
mance on the NBAS, although specific findings vary across 
Compared to unexposed neonates, neonates with a history of prenatal cocaine 
and polydrug exposure exhibit poorer state r e g ~ l a t i o n , ~ ~ ~ ~ ~ ~ ' ~  motor maturi- 





























































Research Reports 21 
i e ~ , ’ ~ ? ’ ~  these findings remained significant even when the effects of con- 
founding variables such as birthweight and prenatal exposure to other drugs 
were controlled analytically. Moreover, significant dose-related effects of 
prenatal cocaine exposure have been reported for infant NBAS perfor- 
mance.’8>’9 
Clinically, full-term infants who have been exposed prenatally to cocaine 
and other drugs have been described as being easily overstimulated and 
requiring increased examiner intervention in order to maintain control of 
their hyperexcitable nervous systems.lh This hypersensitivity and need for 
examiner intervention is still described at one month of age.I6 Some exposed 
infants are unable to tolerate even low levels of stimulation and quickly reach 
an agitated crying state. 
Early detection of neurobehavioral abnormalities such as those revealed 
on the NBAS is important for infants prenatally exposed to drugs and other 
high risk infants. These behaviors may represent early manifestations of 
potential insult to the nervous system which may contribute to later compro- 
mised developmental outcome. Unfortunately, few developmental assess- 
ments designed to capture neurobehavioral organization beyond the newborn 
period are available.a-’ 
Most investigators have used the Bay ley Scales of Infant Development 
(BSID) or other psychometric assessments to evaluate the effects of prenatal 
cocaine exposure on infant outcome beyond the neonatal period. In the ma- 
jority of these studies, prenatal cocaine exposure was not significantly related 
to infants’ performance on either the Mental Developmental Index (MDI) or 
the Psychomotor Developmental Index (PDI).2“26 Billman and colleagues27 
reported that PDI scores varied according to infant exposure status, but o n l y  
when infant cthnicity was considered. That is, black infants who had been 
exposed to cocaine and other drugs had higher PDI than black control infants; 
however, no significant difference was reported for white infants.” In other 
research Singer and associates2s reported differences on the BSID MDI at 12 
months favoring the control group. 
Psychometric assessments such as the BSID may be too limited in sensi- 
tivity and specificity to  detect subtle neurobehavioral deficits that may be 
associated with prenatal drug e x p o s ~ r e . ” > ~ ~ > ~ ~  Beeghly and Brazelton2?’ have 
demonstrated that qualitative dimensions of two-year-old behavior assessed 
during the BSID can significantly discriminate biological at-risk small for 
gestational age (SGA) infants from non-SGA infants, even when the BSID 
scorcs did not. The instrument used in this study, the Qualifier Scoring 
System for Toddlers (QSS-T), was adapted from the NBAS supplementary 
items and measured the quality of a child’s responsiveness during testing on 





























































2-3 PHYSICAL & OCCUPATIOM4L THERAPY IN PEDIATKICS 
tion and more negative affect during the BSID than non-SGA toddlers, and 
required more examiner persistence to complete testing. 
Standard measurement systems for assessing qualitative dimensions of 
infant neurobehavior during the first year of life are lacking. This is unfortu- 
nate because empirical research suggests that prenatal drug exposure may 
exert significant compromising effects on dimensions of infant attention 
regulation and arousal modulation during this period. Struthers and HansenS1 
reported that infants exposed to cocaine and amphetamines performed signif- 
icantly worse than unexposed infants on the Fagan Test of Infant Intelligence, 
a motor-free standardized test of visual attention and recognition. Alessandri 
and colleagues3? found that infants who had been exposed to cocaine prena- 
tally expressed less interest and joy during a learning task and less anger and 
sadness during extinction than unexposed infants. Mayes and her cot- 
leagues3S reported that three-month-old infants with a history of prenatal 
cocaine and other drug exposure were more likely to cry and exhibit negative 
affect during a novel stimulus presentation task and show greater decrements 
in  calming down to repeated presentations than same age unexposed infants. 
In a related study, Mayes and colleagues34 found that infants in the ex- 
posed group were more likely to fail to start an habituation procedure and 
were more irritable during the early part of the procedure than infants in the 
unexposed group. Among the subset of infants who successfully completed 
the habituation paradigm, however, no group differences in habituation per- 
formance were observed. Given the comparable performance between the 
two groups on the habituation task, Mayes et suggest the early effects of 
drug exposure may be particularly evident in qualitative dimensions of infant 
behavior such as arousal modulation and attention regulation, rather than 
early cognitive abilities. 
The aim of the present study was to evaluate the effect of prenatal cocaine 
and other drug exposure on infants’ neurobehavioral functioning at 1, 4 and 7 
months of age. Infants were observed longitudinally in multiple neuromotor 
testing contexts at 1, 4 and 7 months of age. We hypothesized that infants who 
had been exposed to cocaine would have poorer scores on measures of neuro- 
bchavioral functioning than unexposed infants at each assessment point. 
METHOD 
Subjects 
Subjects included 49 infants: 23 control and 26 infants exposed to cocaine. 
Detailed maternal and infant demographic information is provided in Table 1. 
Of the 49 infants, 28 were females and 36 were African American. All were 
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Age (years)* 22 9 (4.5) 28.3 (2.9) 
Parity** 2.4 (1.1) 3.5 (2.0) 
Education (years) 11.8 11.1 







TOBACCO* 5/20 17/21 
* p < 0.01 
** p < 0.05 
)*AFDC Aid to Families with Deoendent Children 
infants were from families living in urban, inner-city dwellings. Transporta- 
tion to and from the study site was provided as w d l  as a payment of $50 per 
visit for their participation in the study. Of the 59 mothers who originally 
agreed to participate in the study, 10 dropped out of the study: 1 from the 
control group and 9 from the drug group. One infant died of sudden infant 
death syndrome, 2 mothers were found to have used heroin during pregnancy 
and 7 failed to keep their appointments. 
Both infant-mother dyads of infants exposed to drugs and control infants 
met the following criteria: (1) mother at least 18 years of age; (2) birth weight 
equal to or greater than 2000 grams; ( 3 )  n o  obvious major congenital mal- 
formations; (4) neonatal intensive care uni t  stay for no more than drug related 
reasons, minor routine observation or septic work-up but with no evidence of 
sepsis; ( 5 )  no requirements for mechanical ventilation; (6) no stigmata of 





























































24 PHKSICAL & OCCUPATIONAL THERAPY IN PEDIATRICS 
tivity for HIV noted in the mother’s or infant‘s medical record; (8) mothers with 
no seizure disorder and no medication for any psychiatric illness; (9) infant 
discharged to mother’s or foster mother’s care from the nursery; and, (10) moth- 
er‘s willingness to give informed consent. 
The mother-infant dyads of the drug exposed group were selected on the 
basis of documented history from the medical chart of substance use during 
pregnancy or on the basis of urine toxicology screens positive for cocaine 
metabolites in the infant following delivery, in the mother at delivery, or 
within one week before delivery as documented in the mother’s or infant’s 
medical record. 
On the basis of medical record review, control dyads delivering within two 
months were matched to experimental dyads for mother’s education and 
socioeconomic status as defined by method of paymcnt for medical care. 
Control dyads also had no documentation in the mother’s prenatal record of 
possible illicit substance use, no positive urine toxic screens for illicit sub- 
stances at any time in the prenatal period, and no positive urine toxic screens 
noted in the infant’s record. In addition, after receiving informed consent 
from the infant’s mother, meconium samples were collected on all control 
infants and screened for the presence of cocaine, opiates, phencyclidine, 
amphetamine and marijuana by radioimmunoassay. 
Procedure 
This study was part of a larger study designed to examine neuromotor 
development in infants exposed to cocaine at 1, 4 and 7 months of 
Items measuring neurobehavioral functioning were scored from videotapes 
of the neuromotor testing sessions. All subjects were tested under the same 
laboratory conditions and submitted to identical procedures during testing. 
At 1 month of age, all infants were tested on kinematic analysis and the 
Alberta Infant Motor Scales (AIMS). At 4 and 7 months of age, all infants 
were tested on kinematic analysis, the AIMS and the Movement Assessment 
of Infants (MAI). All neuromotor testing sessions were videotaped. Of im- 
portance to this study was the “context” of testing rather than the actual 
motor test as the types of events and handling procedures occurring during 
testing became the stressful agent against which neurobehavioral functioning 
would be measured in the infants. 
Kinematic analysis captures and analyzes movement in three dimensions 
through video tracking of the displacement of light reflecting markers placed 
on the infant. During kinematic testing at 1 and 4 months, the infants were 
placed in an infant seat and light reflecting markers were placcd on their  
foreheads, wrists and ankles. The infants’ movements were observed under 
three conditions lasting 2 minutes each: infant alone, with a rattle shaken in 





























































Research Reports 25 
kinematic testing at 7 months, a reaching task was conducted. The infants 
were seated in a high chair and light reflecting markers were placed on their 
foreheads and wrists. The infants then reached up to 30 times for small 
objects presented by the examiner. 
The AIMS is a motor screening assessment made of 58 motor items 
observed in four different positions: prone, supine, sitting and standing.36 
After kinematic testing, the infant was undressed, placed on a floor mattress 
and observed in each position. In order to pass an item, key motor descriptors 
must be observed: aspects of weight bearing, posture and antigravity move- 
ment. The AIMS involves minimal handling and is designed to score the 
observed motor behaviors elicited by the examiner, parent or age appropriate 
toys. 
The MA1 measures neurological and motor integrity through testing of 65 
items divided into four sections on muscle tone, primitive reflexes, automatic 
reactions and volitional movement.37 To score the MAI, a high-risk point is 
given when an item differs from the scores listed on the high-risk profile. The 
MA1 involves extensive infant handling to produce the required reactions. 
Ideally, an infant had to be in an alert state for testing. If the infant became 
fussy or cried, the examiner used different strategies in order to assist the 
infant in maintaining or reaching a state suitable for testing. These strategies 
could be mild (use of face, voice, touch, change of position, offer a toy, 
time-out), moderate (pacifier, arm and leg containment, hand to mouth faci- 
litation, shortened duration of tested item, time-out) or maximal (pick up and 
hold, bottle, rock, walk, break with mother). If the baby still could not reach 
and maintain an alert state for testing, the session was considered incomplete 
and rescheduled. Even when rescheduled, some infants were still unable to 
complete the requirements for kinematic, AIMS or MA1 testing; the kinemat- 
ic session was either shortened or some items from the AIMS or MA1 were 
left unscored. In these situations, the subject’s testing session was coded as 
not completed. 
Data Collection 
The infants’ kinematic and neuromotor testing sessions were conducted by 
examiners unaware of the exposure status of the infants. Measures of neuro- 
behavioral functioning were coded from the videotaped neuromotor testing 
sessions by one of the examiners (Y.B.). At each age, neurobehavioral scores 
were determined based on the type of neuromotor testing (kinematics and 
AIMS at 1 month; kinematics, AIMS and MA1 at 4 and 7 months). Infant and 
maternal demographic information was available from three sources: the 
infant’s and mother’s medical chart at recruitment, the Hobel, and a question- 





























































26 PHKSICAL & OCCUPATIONAL THERAPY IN PEDIATRICS 
Measures 
The neurobehavioral items are listed in Table 2. For those items using a 
scale from 1 to 9, a coding system was adapted from the NBAS supplementa- 
ry items.38 The scale from l to 9 reflected the testing situation used in the 
study and the typical responses seen in 1, 4 and 7 month old infants. An 
example of the scoring scale for general irritability is shown in Table 3. 
In  the first phase of the study, a pilot sample of ten subjects (the first ten 
subjects to  be tested on kinematic, AIMS and MA1 at I, 4 and 7 months) was 
scored on each of the rteurobehavioral items and the final definition of each 
score determined. Following this first phase, intra and inter-rater reliability 
was determined using intraclass correlation  coefficient^.^^ To determine in- 
tra-rater reliability, the experimenter (Y.B.) coded the neurobehavioral items 
from the testing sessions of the 10 pilot subjects and then recoded the items a 
second time. To determine inter-rater reliability, one of the project’s research 
assistants was trained on the coding system and codcd the neurobchavioral 
itcms from 4 subjects previously coded by the experimenter. Intra-class coef- 
ficients (ICC) were calculated and were as follows (intra-rater; inter-rater): 
number of state changes (0.97; 0.95); number of interruptions (1.0; 0.98); 
number of breaks (1.0; 1 .0); predominant state (0.95; 1.0); general irritability 
(0.98; 1 .(I); quality of alert responsiveness (0.99; 0.94); regulatory capacity 
(0.99; 0.97); tolerance to testing (0.98; 0.95); and, examiner persistence 
(0.99; 0.96). All the ICC scores were indicative of high inter or intra-rater 
r e l i a b i l i t ~ . ~ ~  
Data Analyses 
The groups were first compared on all maternal and infant demographic 
variables using ANOVA or Chi-square analyses. For those continuous demo- 
graphic variables on which significant group differences were found, correla- 
tions between that variable (confounder) and all outcome variables were 
determined. In order to examine the influence of a confounder on outcome, 
the study hypotheses were tested using hierarchical regression analyses for 
all those outcome variables significantly correlated with a confounder. All 
other outcome variables were compared using ANOVA or Chi-square tests. 
RESULTS 
Group Comparisons on Infant and Maternal Demographic Variables (Table 1) 
The exposed infants were significantly lower in birth weight than the 
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TABLE 2. Definitions of Measures of Neurobehavioral Functioning 
#of state changeslminute: the total number of state changes divided by the total number of minutes needed to complete testing. 
# breakslminute: the total number of breaks divided by the total number of minutes needed during testing. A break was a rest 
period that occurred when the infant could not reach and maintain an alert state for testing. 
4 # interruptions/min~e: the total number of interruptions divided by the total number of minutes needed for testing. An interruption 
occurred when the infant had to be handled for adjustment or repositioning. 
#visits: number of visits needed to complete testing. 
Time duration: the length of time in minutes and seconds required for testing 
percentage of infants who completed the testing session. 
Session completed: to indicate if testing was completed (yes) or partiallylnot completed (no). Results are presented as the 
Predominant state: the most common state of consciousness observed during testing: deep sleep, light sleep. drowsy, alert, fussy, 
crying. Results are presented as the percentage of infants with the alert state as the predominant state 
during testing. 
*Quality of alert responsiveness: quality of the alert infant's capacity to invest himself in a response to an animate or inanimate 
*Regulatory capacity: ability of the infant to maintain an alert state by himself during testing and the strategies demonstrated to 
*General irritability: infant's response to handling and stimulus situations encountered during testing. It measures the number 
stimuli (scale 1.9). 
maintain and/or return to an alert state before requiring examiner assistance (scale 1-9). 
of times the infant was irritable, the level of irritability and the kind of stimuli causing the irritability 
(scale 1-9). - *Tolerance to testing: amount of stress induced by the demands of attention required during testing on the physiologic, motor 
*Examiner persistence: summary score of the amount of examiner assistance necessary to facilitate the infant's optimal 
and state systems (scale 1-9). 
performance during testing (scale 1-9). 
*scored only during AIMS and MA1 testing 
with any of the outcome variables. The age at testing at 7 months was 
statistically higher for the exposed group when compared with the control 
group (p = 0.02) and was significantly correlated with ratings of examiner 
persistence at 7 months (r = -0.444. p = 0.04 Bonferroni corrected). The 
exposed mothers were significantly older (p < .01), had more children (p = 
0.04), and were more likely to use alcohol (p < .01), marijuana (p < .01) and 
tobacco (p < .01) during pregnancy than control mothers (Table I). Of these 
variables only maternal parity was significantly correlated with the number 
of interruptions per minute during kinematic testing at 1 month (r = 0.458, p = 
0.002) and 7 months (r = 0.366, p = 0.02). 
Group Comparisons on Measures of Neurobehavioral Fiiizctioning 
In the first phase of this analysis, group comparisons using ANOVA or 





























































28 PMSICAL & OCCUPATIONAL THERAPY IN PEDIATWCS 
TABLE 3. General Irritability Scoring Scale 
The general irritability score reflected the infant’s response to handling and stimulus situations encountered during the examination. 
Measures the number of times the infant was irritable, the level of irritability and the kind of stimuli which made himlher irritable. 
1-Irritable throughout the testing session. State 6 (crying) during most of the session. Irritability at beginning of examination that 
increased with time. Examiner unsuccessful at calming infant, testing session terminated early. 
2-Irritability began early during the testing procedure. Reached state 6 (crying) or 5 (fussing); needed break early in testing. 
Remained irritable, calmed for brief periods but not long enough for testing to be continued. Testing procedure not completed. 
3-Irritability began duringor after AIMS was completed. Remainedeasily irritable, reaching state6 (crying) 1 or 2 times but mostly in 
state 5 (fussing) during testing. Might not complete exam. 
4-Easily irritable. However, state 6 (crying) reached only for very brief periods or baby heard crying briefly during testing. Increased 
fussiness and irritability over time. Needed break, recovered, but examiner might decide not to complete exam. 
5-Some irritability with 2-3 episodes of state 5 (fussing). Fussiness was heard but able to complete session with examiner 
intervention and time-out periods. 
6-Reached state 5 (fussing) 1 or 2 times briefly. Returned to quiet alert state spontaneously or with mild examiner intervention. 
Exam completed. 
7-2 or more brief episodes of fussiness during testing but self-control regained rapidly, i.e., within 5 seconds. Might briefly reach 
state 5 (fussing) once. Exam completed. 
8-1-2 brief episodes of fussiness, did not reach state 5 (fussing) but fussing heard. 
9-No irritability; infant responded to all stimulus and handling conditions with well-maintained self-control. 
correlated with a confounder. None of these analyses resulted in significant 
group differences (Tables 4 and 5). 
The second phase of analysis was conducted for those outcome variables 
reported above that were significantly correlated with infant or maternal 
demographic variables (confounders). Hierarchical regressions, as an approach to 
analyses of covariance, 40 were used for this purpose. This approach allows 
interpretation of the data in terms of variance accounted for by the covariate 
and then any additional variance accounted for by group membership, in this 
case drug exposurc (incremcnt in R’). For each analysis, the confounder was 
entered first and then group membership. The increment in R’ was then 
tested for significance and partial R2s computed for the group variable. Prior 
to these analyses all interactions between the confounder and group member- 
ship were tested to rule out violation of the homogeneity of regression as- 
sumption. The inclusion of the interaction term in the regression analysis 
tests for slope differences between drug exposed and control groups. 
As can be seen in Table 6 the infants’ age at testing significantly predicted 
examiner persistence at 7 months accounting for 9.7 percent of the variance 
(R’ = .097). Drug exposure did not account for any additional variance 
indicated by a zero increment in R2. A significant interaction between mater- 
nal parity and group for number of interruptions during kinematics testing at 
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TABLE 4. Means, Standard Deviations and Percentages of Scores During 
Kinematic Testing at I ,  4 and 7 Months 
Dependent Variables 1 Month 4 Months 7 Months 
Exposed 
#visits 1.17(,38) 
# breaksiminute 0.05(.07) 
# interruptionsiminute 0.46(.31) 
Time duration 8.35(1.8) 
% session completed 63% 
% predominant state 4 75% 






























10.81 (2.1) 10.1 6(3.6) 
100% 91% 
0.07(.16) 0.07(.17) 
TABLE 5. Means, Standard Deviations and Percentages of Scores During 
AIMS Testing at 1 Month and AIMS/MAI Testing at 4 and 7 months 
Dependent Variables 1 Month 4 Months 7 Months 




% predominant state 4 
# state changesirninute 
General irritability 
Tolerance to testing 
Examiner persistence 
Quality alert responsiveness 
Regulatory capacity 
Exposed Control Exposed 
96% 95% 95% 
O,OO(.OO) 0.03(.13) 0.03(.06) 
0.07(.17) 0.03(,09) 0.01(.03) 
3,20(1.2) 3.73(1 .I) 17.14(3.4) 
88% 73% 100% 










































indicating a significant slope difference and therefore making a regression 
analysis invalid. Within group regressions of parity on this outcome variable, 
however, indicated that parity predicted interruptions for the control infants 
but was unrelated within the group of infants exposed to drugs. An outlier 
within the group of infants exposed to cocaine (one mother with 10 children) 
was then removed and the analysis rerun. Analysis of the interaction between 
parity and group on interruptions at one month was still significant after 
removal of this outlier. Within group regressions indicated that parity was 
now significantly related to number of interruptions at one month for both 
groups (see Table 6).  Figure 1, however, illustrates that the slope of the 
regression within the group of infants exposed to cocaine is much greater 
indicating that increases in the need to interrupt testing occurred for infants 
with fewer siblings in this group than for the control infants. The interaction 





























































30 PHYSICAL (4; OCCUPATIONAL THERAPY IN PEDIATRICS 
TABLE 6. Hierarchical Regression Analyses of Covariance Results 
~ ~ 
Covariate 
Age at testing r CumR2 F P  k2  P partial R2 
Examiner Persistence at 7 mosl 
Age at test x Group 137 <1 ns 
Groupidrug exposure 312 097 <i ns 0 ns 
Age at testing 311 097 4 4  04 
0 
Maternal Parity r C m R 2  F P  1112 P padfa/ R2 
#of interruptions Kinematics 1 rno 
With outlier 
Parity x Group 323 4 1  037 
Cocaine exposed 352 2 7  ns 
Controls 543 7 9  011 
Within Group Regressions 
Without outlier 
#of interruptions Kinematics 1 rno 
Parity x Group 315 4 3  045 
Cocaine exposed 523 6 7  018 
Controls 543 7 9  011 
Parity x Group 245 2 8  102 
Parity 366 134 6 2  017 
Within Group Regressions 
# of interruptions Kinematics 7 mo 
Groupidrug exposure 368 135 4 ns 001 ns 001 
and hierarchical regression analyses indicated that drug exposure did nut 
account for a significant amount of variance over and above that accounted 
for by parity on this variable. 
DISCUSSION 
This study was designed to examine the possibility of persisting difficul- 
ties in neurobehavioral functioning beyond the neonatal period for infants 
prenatally exposed to cocaine and other drugs. The available research, though 
limited, suggests that the neurodevelopmental sequelae of prenatal drug ex- 
posure appear to be expressed primarily in the general domain of arousal 
regulation experienced in novel or stimulating ~ituations."~'~ Impaired 
arousal regulation, in turn, influences infants' attentional capacities and their 
reactivity to stimulation, including their responsivity to both inanimate and 
animate stimuli.38 In this indirect way, prenatal drug exposure may exert 
long-term compromising effects on children's learning. The lack of sensitive 
instruments able to capture, at times subtle, neurobehavioral markers has 
potentially contributed to the limited amount of research in this area beyond 
the newborn period. This study represents a first attempt to examine neurobe- 
liavioral functioning beyond the newborn period in infants exposed prenatal- 
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FIGURE 1. Relation Between Maternal Parity and fnterrup~ion~/Minute Dur- 
ing Kinematic Testing at One Month 
0.8 I 
I- ~t ! 0.6 
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5 0.2 - 
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0 ’  I I I I 
1 2 3 4 5 
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The results of this longitudinal study, however, did not offer significant 
support to prior empirical or clinical reports of increased irritability and 
disrupted neurobehavioral functioning among older infants exposed to drugs. 
None of the measures of neurobehavioral functioning showed any significant 
group differences. Interestingly, some maternal and infant demographic vari- 
ables showed more effects on neurobehavioral functioning than group expo- 
sure status. Age at testing at 7 months significantly predicted examiner per- 
sistence at 7 months but drug exposure did not (Table 6). The results shown 
in Table 6 show a positivc correlation between examiner persistence and age 
at testing at 7 months (0.31 1) indicating that older infants had higher scores 
on examiner persistence, ie, they required less examiner persistence. Older 
infants were thus easier to test. This relationship was as would be expected 
even though measures of examiner persistence have not been normed for 
infants beyond the newborn period. 
A significant interaction was found between parity and group for the 
number of interruptions during kinematic testing at 1 month of age. After 
removal of an outlier in the drug exposed group (one mother had 10  chil- 
dren), parity was shown to be significantly related to number of interruptions 





























































32 PHYSICAL & OCCUPATIONAL THEM PY IN PEDIATRlCS 
groups (r = 0.523). As can be seen on the slopes shown in Figure 1, however, 
this relationship was different between exposure groups. Fewer children were 
required in the cocaine group to change the slope of the relationship between 
the two variables. At one month of age, in the exposed group, an increase in 
one child in the family caused the number of interruptions to increase where- 
as in the control group, an increase in two children in the family was needed 
to cause an increase in the number of interruptions during kinematic testing. 
The number of interruptions per minute was an indicator of the number of 
additional or unplanned handling procedures introduced during testing. For 
example, interruptions occured to reposition infants or when Velcro bands 
holding the reflecting markers moved or detached; if an infant was very 
active, the bands would move and the markers could no longer be seen by the 
two recording cameras. Additionally, during kinematic testing at one month, 
interruptions occured when the infant's posture had to be corrected. Some 
infants showed an influence of the asymmetrical tonic neck reflex on their 
posture; testing had to be interrupted to place the infant's head in midline in  
order to minimize the influence of this reflex. Our results suggest that infants 
with more siblings were more demanding in attention during kinematic test- 
ing at one month and that among the infants exposed to cocaine and other 
drugs, the effects of parity occur with fewer siblings in the family. The reason 
why parity influenced the number of interruptions at one month during kine- 
matic testing is difficult to interpret. Possibly mothers who use drugs differ in 
their handling of their infants when multiple childrcn are in the home and 
perhaps are less able to divide their attention and respond to their infant's 
needs for consoling. Mothers who use drugs may also be more stressed by an 
additional child which could lead to difficulties in the development of orga- 
n ized behavior. 
In this study, we could not determine if the infants' neurobehavioral scores 
were within or below established norms. No such norms exist and very little 
is known about neurobehavioral functioning beyond the newborn period. As 
in most studies of prenatal drug exposure, the families from both groups in 
this study were from low socioeconomic backgrounds and were benefiting 
from AFDC assistance, more commonly known as welfare services. This bias 
in the studied populations was also found in a study examining the preva- 
lence of substance use during pregnancy.41 The results of that study showed 
that, even though no racial or social class differences among the identified 
substance using pregnant women were noted, black and poor women wcre 
more likely to be reported for substance abuse while pregnant than their 
white and middle class counterparts. Frank and colleagues4' have proposed 
that long-term negative effects of prenatal cocaine exposure might be more 
representative of outcome in a population of poor children living in d 
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prenatally exposed to drugs, Chasnoff and colleagues suggested that low-in- 
come children, regardless of their prenatal drug exposure status, are at risk 
for developmental delays early in life. In their study, children from both 
groups scored below national norms on the Bayley Scales of Infant Develop- 
ment.16 The infants of this study also showed scores on the neuromotor 
assessments, is . ,  AIMS and MAI, that were below average for both groups.3s 
To examine the effects of prenatal drug exposure without the co-morbid 
influences of poverty, future studies would need to include groups of exposed 
and control subjects from higher socioeconomic levels. In fact, socioeconom- 
ic status and mother’s level of education have long been recognized as signif- 
icant predictors of developmental outcome in infants born 
For this study, detailed information on the family home environment was 
not collected. Although understudied, postnatal environmental factors such 
as consistent, sensitive caregiving or early intervention services can signifi- 
cantly moderate the toxic effects of prenatal cocaine exposure and help pro- 
mote healthy adaptation in children exposed to drugs p r e n a t a I l ~ . ~ ~ > ~ ~  In one 
longitudinal study, increased maternal sensitivity and maternal psychological 
adaptation during the first year of life predicted higher Bayley scores in 
infants prenatally exposed to cocaine and other drugs.47 In other research,48 
mothers using drugs who received support services were more likely than 
other mothers to provide a developmentally supportive environment for their 
infants and to have infants whose developmental skills were age-appropriate 
at age one. Similarly, Frank and colleagues49 showed that, among infants 
heavily exposed to cocaine in utero, BSID scores during the first two years of 
life were significantly higher if the infants or their caregivers had received 
early intervention services. Although these factors were not measured in the 
present study, their influence may have masked actual effects of prenatal drug 
exposure on infant neurobehavioral functioning. In future studies with drug 
exposed samples, the moderating effects of these environmental variables 
should be assessed. 
While neurobehavioral dysfunction has been reported for newborn inpants 
exposed to cocaine and other drugs, these findings have not been consistently 
replicated and have not been found to indicate severe neurobehavioral dys- 
function. As these signs of dysfunction have not been readily demonstrated 
beyond the newborn period, they might reflect only transient effects of prena- 
tal exposure that are not present later in development. The possibility exists 
that the outcome variables in this study were not sensitive enough to capture 
subtle difficulties in neurobehavioral functioning in 1-, 4- and 7-month-old 
infants. This is unlikely as the measures used in this study were adapted from 
the NBAS neurobehavioral qualifiers, which are designed to assess these 
dimensions. Besides the Qualifier Scoring System for Toddlers (QSS-T),23 
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able. The QSS-T, an adaptation of the NBAS supplementary items designed 
for use with two-year-old children during structured testing contexts, was 
able to discriminate between biologically high risk infants and lower risk 
infants. The results of this study suggest that qualitative dimensions of func- 
tioning are sensitive measures of risk. More efforts in the design of such 
instruments need to be made in the future. 
Similar to the NBAS which uses the neurological examination as the 
vehicle to induce stress in the newborn infant, the testing conditions imposed 
in this study during kinematic assessment, AIMS, and MA1 testing placed 
challenging demands on the infants. In fact, the general measures of neurobe- 
havioral functioning at 4 and 7 months during AIMS and MA1 testing 
showed a range of scores from 2 to 9. Although most of the infants showed 
scores between 7 and 9, the presence of low scores indicated that the testing 
conditions were able to elicit a wide range of behaviors, from organized to 
disorganized, in the tested infants. 
Some of the early research on prenatal cocaine exposure presented meth- 
odological weaknesses such as lack of control for polydrug use including 
opiates, small sample size, inclusion of preterm infants, and lack of blind 
 examiner^.^' In this study, we attempted to control for confounding variables 
and biases although still using a relatively small sample of polydrug users. 
The subjects were all fullterm infants with birth weight above 2500 grams 
and from the same (low) socioeconomic class, all control infants were free of 
drug exposure, and the examiner was unaware of the exposure status of the 
infants. All infants were tested in the same rooms at the three ages under an 
identical protocol of testing. Despite these precautions, group differences 
were not detected. Our findings do not support the presence of a marked or 
persisting dysfunction in neurobehavioral organization among infants ex- 
posed to cocaine and other drugs. In future studies, infants and children from 
all sub-groups of drug users, including middle class mothers, should be 
examined in order to separate the effects of prenatal cocaine exposure from 
the potential effects of suboptimal rearing environments. 
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